Publication

Urinary Soluble CD163 in Active Renal Vasculitis

O'Reilly, V. P., Wong, L., Kennedy, C., Elliott, L. A., O'Meachair, S., Coughlan, A. M., O'Brien, E. C., Ryan, M. M., Sandoval, D., Connolly, E., Dekkema, G. J., Lau, J., Abdulahad, W. H., Heeringa, P., Buckley, C., O'Brien, C., Finn, S., Cohen, C. D., Lindemeyer, M. T., Hickey, F. B., O'Hara, P. V., Feighery, C., Moran, S. M., Mellotte, G., Clarkson, M. R., Dorman, A. J., Murray, P. T., Little, M. A. & Sanders, J., Sep-2016, In : Journal of the American Society of Nephrology. 27, 9, p. 2906-2916 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • Urinary Soluble CD163 in Active Renal Vasculitis

    Final publisher's version, 1 MB, PDF document

    Request copy

DOI

  • Vincent P. O'Reilly
  • Limy Wong
  • Claire Kennedy
  • Louise A. Elliott
  • Shane O'Meachair
  • Alice Marie Coughlan
  • Eoin C. O'Brien
  • Michelle M. Ryan
  • Diego Sandoval
  • Emma Connolly
  • Gerjan J. Dekkema
  • Jiaying Lau
  • Wayel H. Abdulahad
  • Peter Heeringa
  • Colm Buckley
  • Cathal O'Brien
  • Stephen Finn
  • Clemens D. Cohen
  • Maja T. Lindemeyer
  • Fionnuala B. Hickey
  • Paul V. O'Hara
  • Conleth Feighery
  • Sarah M. Moran
  • George Mellotte
  • Michael R. Clarkson
  • Anthony J. Dorman
  • Patrick T. Murray
  • Mark A. Little
  • Johannes Sanders

A specific biomarker that can separate active renal vasculitis from other causes of renal dysfunction is lacking, with a kidney biopsy often being required. Soluble CD163 (sCD163), shed by monocytes and macrophages, has been reported as a potential biomarker in diseases associated with excessive macrophage activation. Thus, we hypothesized that urinary sCD163 shed by crescent macrophages correlates with active glomerular inflammation. We detected sCD163 in rat urine early in the disease course of experimental vasculitis. Moreover, microdissected glomeruli from patients with small vessel vasculitis (SVV) had markedly higher levels of CD163 mRNA than did those from patients with lupus nephritis, diabetic nephropathy, or nephrotic syndrome. Both glomeruli and interstitium of patients with SW strongly expressed CD163 protein. In 479 individuals, including patients with SW, disease controls, and healthy controls, serum levels of sCD163 did not differ between the groups. However, in an inception cohort, including 177 patients with SW, patients with active renal vasculitis had markedly higher urinary sCD163 levels than did patients in remission, disease controls, or healthy controls. Analyses in both internal and external validation cohorts confirmed these results. Setting a derived optimum cutoff for urinary sCD163 of 0.3 ng/mmol creatinine for detection of active renal vasculitis resulted in a sensitivity of 83%, specificity of 96%, and a positive likelihood ratio of 20.8. These data indicate that urinary sCD163 level associates very tightly with active renal vasculitis, and assessing this level may be a noninvasive method for diagnosing renal flare in the setting of a known diagnosis of SW.

Original languageEnglish
Pages (from-to)2906-2916
Number of pages11
JournalJournal of the American Society of Nephrology
Volume27
Issue number9
Publication statusPublished - Sep-2016

    Keywords

  • SCAVENGER RECEPTOR CD163, DISEASE, GRANULOMATOSIS, IDENTIFICATION, REMISSION, SEVERITY, MARKER, LEVEL

View graph of relations

ID: 35845214